secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2026-03-19T23:59:59+00:00
Accession:  0001171843-26-001777
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ISS recommends Aptose shareholders vote FOR Hanmi arrangement at C$2.41/share
-----------------------------------------------------------------------------

- ISS recommends voting FOR the arrangement with Hanmi Pharmaceutical and the continuance to ABCA.
- Shareholders to receive C$2.41 per share cash, a 28% premium over the 30-day VWAP of C$1.88.
- Special meeting reconvened to March 31, 2026; proxy deadline is March 27, 2026 at 11:00 AM ET.
- Board of directors unanimously recommends approval of the arrangement resolution.
- Completion subject to court approval, TSX approval, and other customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000117184326001777/0001171843-26-001777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000117184326001777/f8k_031926.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-001777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer